Digital Oncology Insights: 11th December - 17th December

1. New "CDEXO" chip uses blood to diagnose lung cancer 10x faster and with higher sensitivity.

Early diagnosis is the most critical factor in surviving lung cancer, and a new technology promises to speed up this process dramatically. Researchers have developed a microfluidic chip called "CDEXO" that can detect lung cancer from a simple blood draw. This innovative chip works by capturing exosomes—tiny chemical messengers released by cancer cells—and analyzing their unique protein signatures. In testing, the CDEXO chip proved to be 10 times faster and 14 times more sensitive than current methods at spotting these elusive cancer markers.

The technology leverages "circular dichroism," a method that uses twisted light to identify specific mutations in proteins. This breakthrough could allow doctors to screen for lung cancer non-invasively, avoiding painful biopsies while catching the disease at a much earlier, more treatable stage. By making high-sensitivity screening faster and more accessible, the CDEXO chip has the potential to save countless lives by flagging tumors long before they become visible on standard scans.

Read the original article at: https://www.futurity.org/blood-draw-lung-cancer-diagnosis-3252152/

2. Liver cancer cases rise 6.5% annually, making it the second leading cause of cancer deaths globally.

Liver cancer is rapidly becoming a global health crisis, with new data revealing a worrying trend. Health experts warn that liver cancer cases are rising by approximately 6.5% every year, a surge that has made it the second leading cause of cancer-related deaths worldwide. This increase is driven largely by lifestyle factors, including rising rates of obesity, diabetes, and alcohol consumption, alongside chronic infections like Hepatitis B and C.

Despite these alarming statistics, awareness remains low. Many patients are diagnosed only in the late stages when treatment options are limited. The medical community is urging a shift toward prevention and early detection, emphasizing that the liver is a resilient organ that can often recover if damage is caught early. Public health campaigns are now focusing on vaccination, regular screenings for high-risk individuals, and lifestyle changes to reverse this deadly trend and reduce the global burden of this preventable disease.

Read the original article at: https://health.economictimes.indiatimes.com/news/industry/learn-about-liver-cancer/114303998

3. CDS tools help Kettering Health Network increase MRI screenings while boosting operational efficiency.

Kettering Health Network has successfully used Clinical Decision Support (CDS) tools to solve a common administrative headache: the complex pre-authorization process for MRI scans. By integrating these digital tools directly into their electronic health records, the network automated the check against "appropriate use criteria." This ensures that every MRI order meets the necessary medical guidelines before it is even sent to insurance, drastically reducing the number of denials.

The impact has been significant. The system not only sped up the approval process, freeing up staff from hours of phone calls with insurers, but also led to a measurable increase in the number of necessary MRI screenings performed. By removing the friction from ordering advanced imaging, doctors were able to get their patients into the scanner faster. This efficient workflow proves that when administrative hurdles are removed through technology, patient access to critical diagnostic care improves alongside hospital operational efficiency.

Read the original article at: https://www.healthcareitnews.com/news/cds-helps-kettering-health-gain-more-mri-screenings-while-boosting-efficiencies

4. Griffin Hospital uses AI to successfully identify more patients eligible for cancer screenings.

Griffin Health has turned to Artificial Intelligence to ensure no patient falls through the cracks when it comes to cancer prevention. The hospital deployed an AI tool designed to analyze patient records and flag individuals who meet the criteria for lung cancer screening but haven't yet been tested. Often, busy primary care doctors might miss these eligibility details during a routine check-up, but the AI system reviews thousands of charts in the background to catch these opportunities.

The results have been impressive, with the AI successfully identifying a significant number of high-risk patients who were subsequently contacted and screened. This proactive approach allows the hospital to catch potential cancers early, when they are most curable. By acting as a "digital safety net," the AI supports clinicians by handling the data-heavy task of risk assessment, ensuring that preventative care protocols are applied consistently across the entire patient population.

Read the original article at: https://www.healthcareitnews.com/news/griffin-health-ai-helps-point-out-patients-clinicians-should-screen-cancer

5. Microsoft unveils "AI Agent Orchestrator" to streamline and coordinate complex cancer care.

Cancer treatment involves a massive amount of data—from genetic profiles to radiology images—and coordinating it all is a major challenge for medical teams. To address this, Microsoft has unveiled a new "AI Agent Orchestrator" specifically designed for oncology. This advanced system acts as a digital conductor, managing multiple specialized AI "agents" that each handle different tasks, such as summarizing patient history, checking clinical trial eligibility, or analyzing pathology reports.

Instead of doctors having to manually toggle between different systems to gather this information, the Orchestrator pulls it all together into a unified view. It uses generative AI to synthesize complex medical data, helping "Tumor Boards" (teams of specialists) make faster, more informed treatment decisions. By automating the heavy lifting of data coordination, Microsoft's new tool aims to reduce burnout for oncologists and ensure that every cancer patient benefits from a comprehensive, data-driven treatment plan without delays.

Read the original article at: https://www.mobihealthnews.com/news/microsoft-unveils-ai-agent-orchestrator-cancer-care-coordination


Follow us on Instagram, Twitter, and Facebook to stay up to date with what's new in healthcare all around the world.

 

Comments

Post a Comment

Popular posts from this blog

Guesswork gone. A new scoring system (ST-RADS) predicts soft-tissue tumor malignancy with 99.2% accuracy.

Image
 Radiologists may soon have a powerful new standard for evaluating soft-tissue tumors. A study detailed in Radiology Business introduces "ST-RADS" (Soft-Tissue Tumor Reporting and Data System), a structured MRI scoring framework designed to replace the often vague descriptive reports currently in use. In a validation study involving roughly 200 patients, the ST-RADS system demonstrated exceptional precision, achieving a 99.2% accuracy rate in predicting malignancy—significantly outperforming the 92.8% accuracy of standard radiological reports. Crucially, the system was perfect (100% accuracy) in identifying benign tumors, a capability that could drastically reduce unnecessary biopsies and patient anxiety. By standardizing how these complex images are interpreted, ST-RADS offers a clear, objective roadmap for clinicians, ensuring that aggressive cancers are flagged immediately while harmless lumps are safely monitored without invasive intervention. Read the original artic...
Read more

The system is too slow. New data reveals that missed "waiting time" targets are hiding the true, deadly cost of cancer care.

Image
 A critical new analysis argues that current targets for cancer treatment waiting times are failing patients and obscuring the true extent of delays. The report highlights that arbitrary benchmarks such as the 62 day target from referral to treatment are frequently missed and do not account for the increasing complexity of modern cancer care. Patients requiring multiple diagnostic tests often face much longer waits that are not accurately reflected in official data. These delays are not merely administrative nuisances they significantly increase the risk of mortality.  The authors contend that simply setting stricter targets is ineffective without addressing the underlying lack of resources. Instead they call for a national learning system driven by data and collaboration to identify bottlenecks in real time and prioritize patients based on clinical urgency rather than outdated metrics. Read the original article at: http://www.bmj.com/content/392/bmj.s14.short?rss=1 Follow ...
Read more

Digital Oncology Insights: 4th December - 10th December

Image
  1. CTCeptor technology simultaneously isolates tumor cells and fibroblasts for better diagnosis. Diagnosing cancer accurately is often difficult because standard liquid biopsies can miss important cells hiding in the blood. To solve this, researchers at DGIST have developed "CTCeptor," a new technology that captures both circulating tumor cells and the "helper" cells (fibroblasts) that support cancer growth. Most current tests try to filter cells based on their size or specific markers, but they often fail to catch cancer cells that look slightly different. CTCeptor uses a unique extraction method that successfully isolates these cells regardless of their size, providing a much more complete picture of the disease. The impact of this technology on patient care could be profound. In recent trials with breast cancer patients, CTCeptor detected 15 times more tumor cells than existing methods. By analyzing both the cancer cells and their environment, doctors can b...
Read more